Skip to main content
MENU
Program
Agenda
CE Information
Educational Supporters
Speakers
Exhibit & Sponsor
Abstracts
Hotel and Travel
Media and PR
Media Center
Press Information
Rates
Heroes in Healthcare
Explore the LL&M Network
Register
View the 2024 Guide
LL&M Travel & Meeting Guide Book
2023 LL&M Highlights
View Video
connect with us
Agenda
+
Available Dates
October 16-19, 2024 | New York City
|
Register
MENU
Agenda
Tracks
NPPA
Spanish
October 16-19, 2024 | New York City
Register
October 16-19, 2024 | New York City
Wednesday October 16, 2024
9:00 AM – 9:05 AM
Welcome and Introduction: Leukemia Day
Speaker
Morton Coleman
MD
+
9:00 AM – 10:30 AM
Session I: AML
Moderator
Gail Roboz
MD
9:05 AM – 9:10 AM
Session Welcome
9:10 AM – 9:30 AM
Updates in AML Diagnosis and Risk Stratification
9:30 AM – 9:50 AM
AML Clinical Management: Getting a Newly Diagnosed Patient on the Right Path
9:50 AM – 10:10 AM
How to Make Stem Cell Transplantation for AML Better, Safer, and More Available?
10:10 AM – 10:30 AM
Q&A Session
10:30 AM – 11:00 AM
Exhibit Hall
+
11:00 AM – 12:45 PM
Session II: MDS
Moderator
Michal Bar-Natan
MD
11:00 AM – 11:05 AM
Session Welcome
11:05 AM – 11:25 AM
Lecture: Clinical and Genomic Characterization of Secondary Myeloid Neoplasms.
11:25 AM – 11:45 AM
Updates in the Treatment of MDS
11:45 AM – 12:05 PM
Q&A Session
12:05 PM – 12:45 PM
Case presentation: TP53 MDS
12:45 PM – 2:00 PM
Lunch Innovation Theater/Symposium (Non-Accredited) (Sponsored by AbbVie)
12:45 PM – 2:00 PM
Lunch Innovation Theater (Non-Accredited) (Sponsored by Amgen)
12:45 PM – 2:00 PM
Lunch Innovation Theater (Non-Accredited) (Sponsored by Servier)
1:00 PM – 2:00 PM
Exhibit Hall
+
2:00 PM – 3:35 PM
Session III: MPN
Moderator
Gail Roboz
MD
2:00 PM – 2:05 PM
Session Welcome
2:05 PM – 2:15 PM
Presentation of Best Leukemia Abstract
2:15 PM – 2:35 PM
Updates in the Management of Polycythemia Vera and Essential Thrombocytopenia
2:35 PM – 2:55 PM
Initiating and Sequencing Treatments for Myelofibrosis
2:55 PM – 3:15 PM
Updates in the Management and Monitoring of CML
3:15 PM – 3:35 PM
Q&A Session
3:35 PM – 4:05 PM
Exhibit Hall
+
4:05 PM – 5:50 PM
Session IV: Challenging Topics in Leukemia
Moderator
Gail Roboz
MD
4:05 PM – 4:10 PM
Session Welcome
4:10 PM – 4:30 PM
Management of CNS Leukemia
4:30 PM – 4:50 PM
Classification and Treatment of Chronic Myelomonocytic Leukemia
4:50 PM – 5:10 PM
Emerging strategies for Ph+ ALL
5:10 PM – 5:30 PM
Fertility Preservation for Myeloid Malignancy Patients
5:30 PM – 5:50 PM
Q&A Session
5:50 PM – 7:15 PM
Welcome Reception
Thursday October 17, 2024
7:30 AM – 8:00 AM
Exhibit Hall
+
8:00 AM – 9:30 AM
Session V: Basic Science: What is New and Exciting!
Moderator
Lisa Roth
MD
8:00 AM – 8:05 AM
Welcome and Introduction: Lymphoma Day
8:05 AM – 8:10 AM
Session Welcome
8:10 AM – 8:30 AM
How Can We Use the Immune System to Better Target Lymphoma?
8:30 AM – 8:50 AM
New Insights into Epigenetics and Lymphoma
8:50 AM – 9:10 AM
Circulating Tumor DNA and Assessment of Risk in Lymphoma
9:10 AM – 9:30 AM
Q&A Session
+
8:00 AM – 9:30 AM
Nurses and Physicians Assistant/ Associate Track: Session A
8:00 AM – 8:05 AM
Welcome and Introduction: Nurses and Physicians Assistant/ Associate Track
8:05 AM – 8:45 AM
Nutrition in Cancer Patients
8:45 AM – 9:30 AM
Fertility Preservation
9:30 AM – 10:00 AM
Exhibit Hall
+
10:00 AM – 11:55 AM
Session VI: Approaches in Indolent Lymphomas
Moderator
Erin Mulvey
MD
10:00 AM – 10:05 AM
Session Welcome
10:05 AM – 10:25 AM
How I Approach Initial Therapy of Follicular Lymphoma
10:25 AM – 10:40 AM
Debate- How to Prioritize Therapy for Patients with R/R FL- CAR-T
10:40 AM – 10:55 AM
Debate- How to Prioritize Therapy for Patients with R/R FL- Novel agents including BTKi, EZH2, iMIDS
10:55 AM – 11:10 AM
Debate- How to Prioritize Therapy for Patients with R/R FL- Bispecifics
11:10 AM – 11:30 AM
Updates in T cell Lymphoma
11:30 AM – 11:55 AM
Q&A Session
+
10:00 AM – 10:55 AM
Nurses and Physicians Assistant/ Associate Track Session B
10:00 AM – 10:55 AM
New Drugs in Hematology/ Oncology
11:55 AM – 1:10 PM
Lunch Innovation Theater (Non-Accredited) (Sponsored by Lilly)
11:55 AM – 1:10 PM
Lunch Innovation Theater (Non-Accredited) (Sponsored by Bristol Myers Squibb)
11:55 AM – 1:10 PM
Lunch Innovation Theater (Non-Accredited)
12:10 PM – 1:10 PM
Exhibit Hall
+
1:10 PM – 3:00 PM
Session VII: Management of Non-indolent Lymphomas
Moderator
John Leonard
MD
1:10 PM – 1:15 PM
Session Welcome
1:15 PM – 1:25 PM
Presentation of Best Lymphoma Abstract:
1:25 PM – 1:35 PM
SASS-ARENA Foundation for Medical Research Award John Ultmann Award for Major Contribution to Lymphoma Research
1:35 PM – 2:00 PM
Award Lecture: What does the Future Hold for Management of Upfront and Relapsed Hodgkin Lymphoma?
2:00 PM – 2:20 PM
Management of Mantle Cell Lymphoma
2:20 PM – 2:40 PM
What’s New in Marginal Zone Lymphoma?
2:40 PM – 3:00 PM
Q&A Session
+
1:40 PM – 3:30 PM
Nurses and Physicians Assistant/ Associate Track Session C
2:10 PM – 3:00 PM
CRS/ICANS Management
3:00 PM – 3:30 PM
Exhibit Hall
+
3:30 PM – 4:55 PM
Session VIII: Aggressive Lymphomas
Moderator
Sarah Rutherford
MD
3:30 PM – 3:35 PM
Session Welcome
3:35 PM – 3:55 PM
How I Approach Initial Therapy of Aggressive Lymphoma
3:55 PM – 4:15 PM
How I approach R/R therapy of Aggressive Lymphoma
4:15 PM – 4:35 PM
Where do CAR-T cells fit in the treatment of aggressive lymphoma?
4:35 PM – 4:55 PM
Q&A Session
+
4:55 PM – 5:25 PM
Session IX- Waldenstrom’s Macroglobulinemia
Moderator
John Leonard
MD
4:55 PM – 5:15 PM
Lecture: The International Waldenstrom’s Macroglobulinemia Foundation Award:The Bruce Waterfall Memorial Lecture
5:15 PM – 5:25 PM
Q&A Session
5:25 PM – 5:25 PM
Adjourn
5:25 PM – 6:40 PM
Dinner Innovation Theater (Non-Accredited)
6:45 PM – 7:45 PM
LRF Grand Rounds
Friday October 18, 2024
7:30 AM – 8:00 AM
Exhibit Hall
+
8:00 AM – 9:30 AM
Session X: Biology and Pathology for Clinicians
Moderator
Mark Bustoros
MD
8:00 AM – 8:05 AM
Welcome and Introduction: Myeloma Day
8:05 AM – 8:10 AM
Session Welcome
8:10 AM – 8:30 AM
The T cell Compartment in MM- Therapeutic Implications of the Bench
8:30 AM – 8:50 AM
Myeloma and the Microenvironment. Comparing Marrow and Extramedullary Disease: Future Directions
8:50 AM – 9:10 AM
Precursor disorders (Smoldering Myeloma): If and When to Treat. Maintenance intervention or going for the cure
9:10 AM – 9:30 AM
Q&A Session
8:00 AM – 9:30 AM
Spanish Session in Lymphoma
Invited Panelist
Astrid Pavlovsky
MD
Moderator
Julio Chavez
MD, MS
Panelist
Peter Martin
MD
+
8:00 AM – 9:30 AM
Nurses and Physician Assistant/ Associate Track Session D
8:05 AM – 8:45 AM
Dermatologic Manifestations of Cancer
8:45 AM – 9:30 AM
Hodgkin's Lymphoma Updates
9:30 AM – 10:00 AM
Exhibit Hall
+
10:00 AM – 11:55 AM
Session XI: Upfront Treatment of Myeloma
Moderator
Jorge Monge
MD
10:00 AM – 10:05 AM
Session Welcome
10:05 AM – 10:25 AM
Is MRD Ready for Prime Time?
10:25 AM – 10:45 AM
Optimal Upfront Treatment: Current and Novel Immunotherapy Approaches
10:45 AM – 11:05 AM
The High Risk Elderly Frail Patient: Should CART or Bispecifics be Incorporated?
11:05 AM – 11:20 AM
Debate: Management of A Fit Patient: Should CAR-T replace autotransplant as consolidation? Transplant
11:20 AM – 11:35 AM
Debate: Management of A Fit Patient: Should CAR-T replace autotransplant as consolidation? - CAR-T
11:35 AM – 11:55 AM
Q&A Session
+
10:00 AM – 10:55 AM
Nurses and Physician Assistant/ Associate Track Session E
10:00 AM – 10:55 AM
Bone Marrow Workshop
11:55 AM – 1:10 PM
Lunch Innovation Theater (Non-Accredited) (Sponsored by Johnson & Johnson)
11:55 AM – 1:10 PM
Lunch Innovation Theater (Non-Accredited)
11:55 AM – 1:10 PM
Lunch Innovation Theater (Non-Accredited) (Sponsored by Bristol Myers Squibb)
11:55 AM – 1:10 PM
Lunch Innovation Theater (Non-Accredited) (Sponsored by Karyopharm)
12:10 PM – 1:10 PM
Exhibit Hall
+
1:10 PM – 3:30 PM
Session XII: Evolving Options in Multiple Myeloma
Moderator
Ruben Niesvizky
MD
1:10 PM – 1:15 PM
Session Welcome
1:15 PM – 1:25 PM
Best Myeloma Abstract Presentation
1:25 PM – 1:40 PM
SASS-ARENA Foundation for Medical Research Award Joseph Michaeli Award for Contribution to Myeloma Research
1:40 PM – 2:10 PM
Award Lecture: The Immune Microenviroment in Myeloma-Therapeutic Implications
2:10 PM – 2:30 PM
How to Incorporate New Therapies in the Early Relapse Patient (1-3 prior lines)
2:30 PM – 2:50 PM
Beyond BCMA Directed CAR-T- Therapy- How New Targets are Being Exploited
2:50 PM – 3:10 PM
T Cell Engagers (Bispecifics) BCMA and Other Targets
3:10 PM – 3:30 PM
Q&A Session
2:10 PM – 3:10 PM
Lumbar Puncture Workshop
Speaker
Jeremy Heinerich
PA-C
2:30 PM – 3:30 PM
Nurses and Physician Assistant/ Associate Track Session F
3:30 PM – 4:00 PM
Exhibit Hall
+
4:00 PM – 6:00 PM
Session XIII: Treatment in Relapsed/ Refractory Multiple Myeloma
Moderator
Ruben Niesvizky
MD
4:00 PM – 4:05 PM
Session Welcome
4:05 PM – 4:25 PM
The Relapsed Refractory Patient: When Immune Approaches are Ineffective
4:25 PM – 4:45 PM
The Multiple Refractory Patient: From Cell Mods to XPO1 Inhibitors
4:45 PM – 5:05 PM
Extramedullary Myeloma: Is There Any Hope? New Treatment Approaches
5:05 PM – 5:25 PM
CAR T-Cell Therapy in Multiple Myeloma: Best Practices in Patient Selection, Treatment, and Multidisciplinary Care
5:15 PM – 5:35 PM
Q&A Session
5:35 PM – 6:00 PM
Case Discussions
6:00 PM – 6:00 PM
Adjourn
6:00 PM – 7:15 PM
Dinner Innovation Theater (Non-Accredited) (Sponsored by Johnson&Johnson)
Saturday October 19, 2024
7:45 AM – 8:15 AM
Exhibit Hall
+
8:15 AM – 9:45 AM
Session XIV: New and Basic Science
Moderator
Richard Furman
MD
8:15 AM – 8:20 AM
Welcome and Introduction: CLL Day
8:20 AM – 8:25 AM
Session Welcome
8:25 AM – 8:45 AM
Is Low Count MBL a Precursor to CLL?
8:45 AM – 9:05 AM
CLL: The next Frontier
9:05 AM – 9:25 AM
Rai Lecture: Recently Born CLL Cells: Youth Is Not Wasted on the Young
9:25 AM – 9:45 AM
Q&A Session
8:15 AM – 9:45 AM
Spanish Session Myeloma
Moderator
Ruben Niesvizky
MD
Panelist
Jorge Monge
MD
Victor Jimenez Zepeda
MD
9:45 AM – 10:15 AM
Exhibit Hall
+
10:15 AM – 12:20 PM
Session XV: Treatment Approaches- Sequential and Combinatorial
Moderator
Richard Furman
MD
10:15 AM – 10:20 AM
Session Welcome
10:20 AM – 10:40 AM
What To Do with BTK Mutation Data
10:40 AM – 11:00 AM
Lecture: Sequencing BTKi vs BCL2- Frontline and Relapsed
11:00 AM – 11:20 AM
Lecture: Combination studies of BTKi and BCl2
11:20 AM – 11:40 AM
The Prince Family Lecture: How Should We Be Using MRD Data?
11:40 AM – 12:00 PM
Management of Richter Transformation
12:00 PM – 12:20 PM
Q&A Session
12:20 PM – 1:35 PM
Lunch Innovation Theater (Non-Accredited) (Sponsored by AstraZeneca)
12:20 PM – 1:35 PM
Lunch Innovation Theater/Symposium (Non-Accredited) (Sponsored by AbbVie)
12:20 PM – 1:35 PM
Lunch Innovation Theater (Non-Accredited)
+
1:35 PM – 3:15 PM
Session XVI: BTKis and CAR-T in CLL
Moderator
Richard Furman
MD
1:35 PM – 1:40 PM
Session Welcome
1:40 PM – 2:00 PM
Lecture: Noncovalent Binding BTK inhibitor - A New Novel Approach/a different binding mechanism
2:00 PM – 2:20 PM
CAR-T cells in CLL
2:20 PM – 2:30 PM
Debate- CLL: Debating Therapeutic Strategies
2:30 PM – 2:40 PM
Debate- CLL: Debating Therapeutic Strategies
2:40 PM – 2:50 PM
Debate- CLL: Debating Therapeutic Strategies
2:50 PM – 3:00 PM
Debate- CLL: Debating Therapeutic Strategies
3:00 PM – 3:15 PM
Q&A Session
3:15 PM – 3:15 PM
Adjourn
Questions?
Contact